← Back

Shanghai Kindly Entrp Dvlp Grp

Shanghai Kindly Enterprise Development Group Co., Ltd. researches, develops, produces, and sells medical devices, including medical puncture needles and infusion devices, worldwide. Its products include syringes, infusion sets, needles, tube bags, medical packing films, sterilization indicator tapes, and intervention accessories such as stopcocks. The company also offers a range of disposable and specialized devices, including coaxial biopsy needles, pump infusion sets, prefilled syringe assemblies, indwelling needles, and arterial blood gas needles. It exports to the United States, Europe, South America, the Middle East, Southeast Asia, and other international markets, and is headquartered in Shanghai, China.

Price · split & dividend adjusted
News & notes moving 603987.CG
China
603987.CG

KDL subsidiary plans to transfer 7% stake in Guangxi Ouwen for 52.5 million yuan

KDL announced that its wholly-owned subsidiary Guangdong Medical Devices Group plans to transfer its 7% stake in Guangxi Ouwen to Ouwen Holding Group, New Era, and New Resonance for 52.5 million yuan. After the transaction, Guangdong Medical Devices Group will hold a 44% stake in Guangxi Ouwen, and Guangxi Ouwen will no longer be included in the company's consolidated financial statements. This transaction does not constitute a related-party transaction, nor does it constitute a major asset restructuring.
Shanghai Kindl…
603987.CG · Capital · Neutral KDL's subsidiary will transfer a 7% stake in Guangxi Ouwen for 52.5 million yuan, reducing its holding to 44% and deconsolidating the unit.
Read original ↗
CLS·8dRead more →
603987.CG▼

KDL Medical's first-half net profit attributable to parent falls 10.2% to 112 million yuan

KDL Medical released its 2026 interim report, showing first-half net profit attributable to the parent of 112 million yuan, down 10.2% year on year. Operating revenue was 1.09 billion yuan, down 3.2%; non-GAAP net profit attributable to the parent was 110 million yuan, down 10.5%; and net operating cash flow was 116 million yuan, up 57.1%. Second-quarter operating revenue was 552 million yuan, down 4.3%, with net profit attributable to the parent of 58.18 million yuan, down 9.6%. The company said market demand for injection and puncture medical consumables is steadily rising, and the market is expected to expand to 35.61 billion US dollars by 2033.
Shanghai Kindl… ▼
603987.CG · Capital · Negative First-half net profit fell 10.2% and revenue declined 3.2%.
Read original ↗
财中社·42dRead more →
China
603987.CG▼

康德莱 first-half net profit attributable to parent falls 10.23% to 112 million yuan

康德莱 announced that in the first half of 2026, the company achieved operating revenue of 1.089 billion yuan, down 3.21% year on year. Net profit attributable to shareholders of the listed company was 112 million yuan, down 10.23% year on year.
Shanghai Kindl… ▼
603987.CG · Capital · Negative First-half net profit attributable to parent fell 10.23% to 112 million yuan, with revenue down 3.21%.
Read original ↗
央广财经·42dRead more →
© 2026 MarketIVAsset